tradmap

TRMB Trimble Inc.

$65.87 +1.42%

Data as of close

S&P 500 Companies

Held by SPYVOOIVV

Healthcare · Measuring & Controlling Devices, Nec

Trimble Inc. (TRMB) is a healthcare company in the Measuring & Controlling Devices, Nec industry, with a market capitalization of $15.4 billion. Shares last traded at $65.87, 22.0% below their 52-week high. Over the past year the stock is down 16.5%. Net profit margin is -2.8%, below the peer median of -1.6%. Revenue declined 2.6% year over year.

Market Cap
$15.4B
Shares Out
233.2M
EPS (TTM)
-$0.48
P/E (TTM)*
—
P/S Ratio
4.06
P/B Ratio
3.01
Dividend / Share
—
Dividend Yield
—
52-Week High
$84.40
52-Week Low
$47.92
Volume (venue)
134,109
Avg Vol (3m, venue)
121,631.635

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+3.95%
1M
+14.48%
3M
+9.00%
6M
-3.90%
YTD
-15.93%
1Y
-16.51%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
70.01
SMA (50)
$59.95
SMA (200)
$60.77
Price vs SMA50
+9.88%
Price vs SMA200
+8.40%
ATR (14)
$1.59

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$3.8B
Net Income
-$105M
Gross Margin
69.8%
Operating Margin
17.0%
Net Margin
-2.8%
Return on Equity
-2.0%
Return on Assets
-1.2%
Current Ratio
0.95
Debt / Equity
0.28
Revenue Growth (YoY)
-2.6%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-07-03. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$2.02 2026-08-12
Q1 2026 $0.42 2026-05-06
Q4 2025 (derived) $0.66 2026-02-25
FY 2025 $1.76 2026-02-25
Q3 2025 $0.46 2025-11-05
Q2 2025 $0.37 2025-08-06

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Measuring & Controlling Devices, Nec peers

TRMB vs 10 industry peers (Measuring & Controlling Devices, Nec), by market cap. Data as of close

P/S vs peers
4.06 / 4.14 med
-2% discount
Net margin vs peers
-2.8% / -1.6% med
below median
1–10 of 10
TMOThermo Fisher Scientific$253.0B35.775.3414.9%-2.03%
ROKRockwell Automation$48.9B40.705.4513.4%+0.87%
TRMBTrimble Inc.$15.4B—4.06-2.8%+1.42%
ONTOOnto Innovation$9.4B—9.34-0.4%-5.02%
MIRMirion Technologies, Inc.$4.5B154.264.142.7%+1.69%
QSIQuantum-Si Inc$274M—170.47—-13.79%
OWLTOwlet, Inc.$126M—1.10-7.8%+6.28%
GEOSGEOSPACE TECHNOLOGIES CORP$53M—0.58-43.1%-7.01%
BCHTBirchtech Corp.$29M—1.49-15.8%-5.65%
NIKINiki BioSolutions, Inc.$1M———-3.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.